Form 4: Stryker Corp Executive William E. Berry, Jr. Reports Stock and Option Grants

William E. Berry, Jr., VP and Chief Accounting Officer of Stryker Corp, reports the acquisition of restricted stock units and employee stock options.

Summary

• William E. Berry, Jr., VP and Chief Accounting Officer of Stryker Corp, filed a Form 4 detailing changes in beneficial ownership.
• On February 5, 2025, Berry was granted 733 Restricted Stock Units (RSUs) and an employee stock option for 2,198 shares.
• The RSUs vest in three equal installments on March 21, 2026, March 21, 2027, and March 21, 2028.
• Each RSU represents the right to receive one share of Stryker Common Stock.
• The employee stock options, granted at a price of $392.39, become exercisable in 20% increments on each of the first five anniversaries of the grant date, expiring on February 4, 2035.
• Following these transactions, Berry directly owns 5,773 shares of Stryker Common Stock and indirectly owns 591 shares through a 401K.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard executive compensation practices, which are generally viewed favorably as aligning management and shareholder interests.

Positives

• The grant of RSUs and stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule of the RSUs and options encourages long-term commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the equity grants suggest an expectation of continued growth and value creation.

Industry Context

Equity grants are a common practice in the medical device industry to incentivize and retain key executives. These grants align management's interests with those of shareholders, encouraging long-term value creation.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation practices among Stryker's peers in the medical device industry, such as Medtronic, Johnson & Johnson (DePuy Synthes), and Zimmer Biomet.
• The vesting schedules and grant sizes are generally comparable to those offered by similar companies to their executive officers.

Stakeholder Impact

• The equity grants align executive interests with shareholder value.
• Employees may be motivated by the knowledge that executives are incentivized to improve company performance.

Key Dates

Keywords

Form 4, Stryker, Stock Options, Restricted Stock Units, Beneficial Ownership, Executive Compensation